Table 1. Demographic and neuropsychological data between the two groups.
AD | NC | p | |
N | 23 | 24 | — |
Sex (Female/male) | 14/9 | 12/12 | 0.454 |
Age (years) | 58.74±4.96 | 54.67±8.69 | 0.055 |
Education Level (years) | 11.35±3.50 | 11.67±3.09 | 0.381 |
MMSE | 14.52±5.23 | 29.13±1.51 | 0.000 |
MoCA | 8.70±4.17 | 27.08±2.84 | 0.000 |
AVLT-immediate recall | 7.78±4.22 | 24.42±6.03 | 0.000 |
AVLT-delayed recall | 0.22±0.52 | 9.38±2.04 | 0.000 |
Digit Span Forwards | 6.91±1.28 | 8±1.14 | 0.007 |
Digit Span Backwards | 2.35±1.37 | 5.25±1.22 | 0.000 |
ADL | 37.22±11.46 | 20±0 | 0.000 |
BNT | 15.18±6.12 | 25.38±3.63 | 0.000 |
CDR | 1.48±0.63 | 0.02±0.10 | 0.000 |
CFT | 6.23±6.49 | 15.04±1.16 | 0.000 |
TMT | 150.18±50.36 | 36.88±44.24 | 0.000 |
Note: Group differences in demographic measures were tested using the independent sample t-test and the Chi-square analyses or Fisher exact test for quantitative and qualitative variables. Statistical significance level was set at P < 0.05 (two-tailed). Abbreviations: MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; AVLT, Rey Auditory Verbal Learning Test; ADL, Activities of Daily Living; BNT, Boston Naming Test; CDR, Clinical Dementia Rating; CFT, Rey-Osteirreth Complex Figure Test; TMT, Trail Making Test; AD, Alzheimer’s disease; NC: normal controls.